PrabhaViswanathanMD

Physician

Dr. Viswanathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Office
US Food and Drug Adminstration
10903 New Hampshire Ave
Silver Spring, MD 20993
Is this information wrong?

Children's National Medical Center/George Washington UniversityFellowship, Pediatric Infectious Diseases, 2010 - 2013
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2003 - 2006
University of Kansas School of MedicineClass of 2003

PubMed

26 citations
Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint.
Sarita D. Boyd, Mario R Sampson, Prabha Viswanathan, Kimberly A Struble, Vikram Arya, Adam Sherwat> ;AIDS. 2019 May 1
2 citations
Effects of Sorbitol on the Pharmacokinetics of Lamivudine Solution and the FDA's Decision to Increase the Dose of Lamivudine Solution for Pediatric Patients.
Su-Young Choi, Prabha Viswanathan, Adam Sherwat, Shirley Seo> ;Clinical Pharmacology and Therapeutics. 2018 Nov 1
6 citations
US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection.
Sarita D. Boyd, LaRee Tracy, Takashi E. Komatsu, Patrick R. Harrington, Prabha Viswanathan, Jeffrey S. Murray, Adam Sherwat> ;Clinical Drug Investigation. 2017 Jan 19
13 citations
Hypoglycemia in Patients Treated With Linezolid
Prabha Viswanathan, Dmitri Iarikov, Ronald T. Wassel, Alma Davidson, Sumathi Nambiar> ;Clinical Infectious Diseases. 2014 Oct 15
Drug Safety Resources for Healthcare Professionals and Consumers.
Prabha Viswanathan, Thomas D. Smith, Sumathi Nambiar> ;Journal of the Pediatric Infectious Diseases Society. 2012 Sep 1
Join now to see all

Journal Articles

Effects of Sorbitol on the Pharmacokinetics of Lamivudine Solution and the FDA's Decision to Increase the Dose of Lamivudine Solution for Pediatric Patients
Prabha Viswanathan, MD, Clinical Pharmacology & Therapeutics